DSI Welcomes a New Director of Business Development

DSI Welcomes a New Director of Business Development


(Harleysville, PA; February 1, 2022) – Design Space InPharmatics (DSI), a full-service CMC consulting firm focused on providing pharmaceutical attributes, regulatory affairs, and drug discovery and development consulting services, is delighted to announce today the appointment of Ben Luts to Director of Business Development. Ben will be joining the Business Development team to expand our regional markets with an initial focus on the West Coast of the United States as well as other up and coming markets in North America.

“Ben will be leveraging his experience in creating robust client bases in highly technical markets to expand our footprint in the CMC outsourcing space. Ben brings with him a proven track record of fostering business growth, from creating new business units and services from scratch to growing strategic large client accounts at a global level. He has worked over 10 years in the life sciences industries with broad experience across all steps in the product lifecycle. I'm excited to see Ben use his background to match our services with client needs in not only existing markets but new ones as well.” said Brian Lihou, Head of Operations of DSI.

Ben Luts obtained his Master 2 in General Management from Aix-Marseille University and a Masters in Neuropsychology from Maastricht University

About Design Space InPharmatics

DSI Space Inpharmatics, a full-service biotech company, is one of the most sought-after CMC consulting firm, helping startups and large scale biopharmaceutical companies globally. The company has established an unparalleled record in helping companies to solve challenges revolving around product manufacturing, regulatory affairs, and quality assurance. With over ten years of operations, DSI has garnered a broad experience to develop your new product from research to manufacturing processes. When it comes to serving clients, DSI thrives in conducting a transparent assessment, timeliness, applying science and technology, accurate submissions, and an effective regulatory plan.

For more information about DSI, kindly connect with us via Tel: 1-855-805-8402, Email: solutions@dsinpharmatics.com, or visit our website www.dsinpharmatics.com